Skip to main content
Log in

Early gain in body mass with continuous positive airway pressure therapy for obstructive sleep apnea

Early body mass gain with CPAP therapy

Anfängliche Gewichtszunahme bei kontinuierlicher Positivdruck-Therapie wegen obstruktiver Schlafapnoe

Anfängliche Gewichtszunahme bei CPAP-Therapie

  • Original Contribution
  • Published:
Somnologie - Schlafforschung und Schlafmedizin Aims and scope Submit manuscript

Abstract

Study objectives

Many clinicians believe that continuous positive airway pressure (CPAP) therapy of obstructive sleep apnea (OSA) is associated with a decrease in body mass, but to date, studies generally suggest long-term stability in body mass after 1 year. We have seen body mass increase after 4 weeks of treatment with CPAP in most patients with OSA. In this study, we test the hypothesis that therapy of OSA with CPAP produces a short-term gain in body mass, and look for physiological correlates to suggest an underlying mechanism.

Methods

Retrospective analysis of 218 consecutive patients treated for sleep apnea at a community-based sleep center.

Results

A total of 152 patients met the criteria for study conclusion. After 1 month of CPAP treatment, 119 subjects (78%) gained mass, including 81% of men and 73% of women. As a group, subjects on CPAP gained 1.4±2.5 kg (mean±SD). The Epworth Sleepiness Scale was reduced after 1 month of CPAP therapy. There was no correlation between gain in body mass and measured parameters. A subgroup of 71 patients remained on therapy. They demonstrated a gain in mass at 4 weeks, which did not persist at 6 months.

Conclusions

CPAP treatment of OSA is associated with gain in body mass at 1 month but not 6 months of therapy. The nature of this gain in mass remains unknown. We believe the gain is due to increased vascular volume, and might represent an early marker of physiological benefit of CPAP. This article includes a review of potential mechanisms for early increase in body mass with CPAP.

Zusammenfassung

Fragestellung

Viele klinisch tätige Ärzte gehen davon aus, dass eine kontinuierliche Positivdruck (CPAP)-Therapie bei obstruktiver Schlafapnoe (OSA) mit Gewichtsabnahme einhergeht, allerdings legen Studien bis heute eine Langzeitstabilität des Gewichts nach einem Jahr nahe. Wir haben bei den meisten Patienten mit OSA nach 4 Wochen CPAP-Therapie eine Gewichtszunahme beobachtet. In dieser Studie prüfen wir die Hypothese, dass die CPAP-Therapie einer OSA mit einer kurzfristigen Gewichtszunahme einhergeht, und versuchen, physiologische Korrelate für mögliche zugrunde liegende Pathomechanismus zu finden.

Methoden

Retrospektive Untersuchung von 218 konsekutiven Patienten, die gegen Schlafapnoe in einem kommunalen Schlafzentrum behandelt wurden.

Ergebnisse

Den Einschlusskriterien der Studie entsprachen 152 Patienten. Nach einer einmonatigen CPAP-Behandlung war bei 119 (78%; 81% der Männern und 73% der Frauen), eine Gewichtszunahme erfolgt (1,4±2,5 kg, Mittelwert ± Standardabweichung: 1,4±2,5 kg). Die Epworth-Schläfrigkeitsskala war nach einem Monat der CPAP-Therapie reduziert. Es gab keine Korrelation zwischen der Körpergewichtszunahme und den gemessenen Parametern. Eine Untergruppe von 71 Patienten führte die Therapie fort. Sie demonstrierten Gewichtszunahme nach 4 Wochen, die sich nicht über 6 Monate hielt.

Schlussfolgerungen

Die CPAP-Behandlung einer OSA ging mit einer Gewichtszunahme innerhalb des ersten Monats einher, die sich nicht über 6 Monate hielt. Die Ursache dafür bleibt unklar. Wir glauben, dass die Gewichtszunahme durch eine Vergrößerung des Gefäßvolumens verursacht wird und dies ein frühes Merkmal für eine physiologische Kompensation sein könnte. Die Diskussion beinhaltet eine Übersicht über die möglichen Mechanismen für die frühe Gewichtszunahme bei der Anwendung von CPAP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Traviss KA, Barr SI, Fleming JA, Ryan CF (2002) Lifestyle-related weight gain in obese men with newly diagnosed obstructive sleep apnea. J Am Diet Assoc 102:703–706

    Article  PubMed  Google Scholar 

  2. Phillips BG, Hisel TM, Kato M et al (1999) Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17:1297–1300

    Article  CAS  PubMed  Google Scholar 

  3. Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31(Suppl 2):S303–S309

    Article  PubMed  Google Scholar 

  4. Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676

    Article  PubMed  Google Scholar 

  5. Punjabi NM, Sorkin JD, Katzel LI et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682

    Article  PubMed  Google Scholar 

  6. Punjabi NM, Shahar E, Redline S et al (2004) Sleep-disordered breathing, glucose intolerance and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530

    Article  PubMed  Google Scholar 

  7. Harsch IA, Konturek PC, Koebnick C et al (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257

    Article  CAS  PubMed  Google Scholar 

  8. Hong S, Dimsdale JE (2003) Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med Sci Sports Exerc 35:1088–1092

    Article  PubMed  Google Scholar 

  9. Loube DI, Loube AA, Erman MK (1997) Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 97:896–897

    Article  CAS  PubMed  Google Scholar 

  10. Redenius R, Murphy C, O’Neill E et al (2008) Does CPAP lead to change in BMI? J Clin Sleep Med 4:205–209

    PubMed  PubMed Central  Google Scholar 

  11. Engleman HM, Asgari-Jirhandeh N, McLeod AL et al (1996) Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 109:1470–1476

    Article  CAS  PubMed  Google Scholar 

  12. Ryan CF, Love LL, Buckley PA (1995) Energy expenditure in obstructive sleep apnea. Sleep 18:180–187

    CAS  PubMed  Google Scholar 

  13. Engleman HM, Gough K, Martin SE et al (1996) Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 19:378–381

    CAS  PubMed  Google Scholar 

  14. Hein H, Kirsten D, Magnussen H (1997) Nehmen Patienten mit obstruktivem Schlafapnoesyndrom unter nCPAP-Therapie ab? Pneumologie 51(Suppl 3):776–778

    PubMed  Google Scholar 

  15. Chin K, Shimizu K, Nakamura T et al (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712

    Article  CAS  PubMed  Google Scholar 

  16. Harsch IA, Schahin SP, Radespiel-Troger M et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162

    Article  PubMed  Google Scholar 

  17. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al (2006) Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129:1459–1467

    Article  PubMed  Google Scholar 

  18. Trenell MI, Ward JA, Yee BJ et al (2007) Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 9:679–687

    Article  CAS  PubMed  Google Scholar 

  19. Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161

    Article  CAS  PubMed  Google Scholar 

  20. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545

    CAS  PubMed  Google Scholar 

  21. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system of sleep stages in human subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles

  22. Stenlof K, Grunstein R, Hedner J, Sjostrom L (1996) Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 271:E1036–E1043

    CAS  PubMed  Google Scholar 

  23. Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556

    Article  CAS  PubMed  Google Scholar 

  24. Cooper BG, White JE, Ashworth LA et al (1995) Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18:172–179

    CAS  PubMed  Google Scholar 

  25. Thum T, Fleissner F, Klink I et al (2007) Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92:4172–4179

    Article  CAS  PubMed  Google Scholar 

  26. Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66

    Article  CAS  PubMed  Google Scholar 

  27. Krieger J, Imbs JL, Schmidt M, Kurtz D (1988) Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 148:1337–1340

    Article  CAS  PubMed  Google Scholar 

  28. Follenius M, Krieger J, Krauth MO et al (1991) Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 14:211–217

    CAS  PubMed  Google Scholar 

  29. Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403–411

    Article  PubMed  Google Scholar 

  30. Umlauf MG, Chasens ER, Greevy RA et al (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27:139–144

    PubMed  Google Scholar 

  31. Baruzzi A, Riva R, Cirignotta F et al (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14:83–86

    CAS  PubMed  Google Scholar 

  32. Krieger J, Follenius M, Sforza E et al (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80:443–449

    Google Scholar 

  33. Krieger J, Laks L, Wilcox I et al (1989) Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci (Lond) 77:407–411

    Google Scholar 

  34. Lin CC, Tsan KW, Lin CY (1993) Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 16:37–39

    CAS  PubMed  Google Scholar 

  35. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen J (1996) Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5:42–50

    Article  CAS  PubMed  Google Scholar 

  37. Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA (1996) Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333–1338

    Article  CAS  PubMed  Google Scholar 

  38. Khoo MC, Kim TS, Berry RB (1999) Spectral indices of cardiac autonomic function in obstructive sleep apnea. Sleep 22:443–451

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the staff of the Regional Center for Sleep Medicine of Toledo, OH. This research was supported by the Metabolic Research and Teaching Fund at University of Toledo.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R.E. Bourey MD, FAASM.

Additional information

Research Site: University of Toledo College of Medicine, Toledo, OH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bourey, R., Bourey, J., Habbal, N. et al. Early gain in body mass with continuous positive airway pressure therapy for obstructive sleep apnea. Somnologie 14, 207–212 (2010). https://doi.org/10.1007/s11818-010-0483-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11818-010-0483-8

Keywords

Schlüsselwörter

Navigation